Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Enliven Therapeutics, Inc. (ELVN)

NASDAQ

$59,29

$-0,36

(-0,60%)

Regular Market

Enliven Therapeutics, Inc. (ELVN) Live Price Chart

Last updated: ⁦2026-09-04 16:59:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Enliven Therapeutics, Inc. (ELVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $59,29, with a market capitalization of $4,32B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14,79 to $62,32. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4,32B
Open	$59,69
Day's High	$62,32
Day's Low	$9,80
Previous Close	$59,65
Volume	90,92K
Average Volume	--
P/E Ratio	--
52-Week High	$62,32
52-Week Low	$14,79
Dividend Yield	--
Earnings Date	--

Enliven Therapeutics, Inc. (ELVN) Stock Price Today

Enliven Therapeutics, Inc. (ELVN) is currently trading at $59,29 as of 2026-09-04 16:57:00, down 0,61% ($0,37) from the previous close of $59,65

During today's regular trading session, ELVN has traded between $9,80 and $62,32, with a trading volume of 90,92K shares. The current price is near the upper end of today's range.

Enliven Therapeutics, Inc. (ELVN) 7-Day Stock Price Change

Over the past seven days, Enliven Therapeutics, Inc. (ELVN) moved from $57,50 to $59,29, representing a gain of 3,10% ($1,78).

The stock traded between $56,93 and $60,00 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 664,94 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ELVN 52-Week Price Position

Position in Range: 93,6%

52W Low$14,79

52W High$62,32

ELVN is currently trading at $59,29, placing it 93,6% of the way from its 52-week low of $14,79 to its 52-week high of $62,32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Enliven Therapeutics, Inc. (ELVN)?

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Enliven Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	67
Exchange	NASDAQ
Company Website	https://www.enliventherapeutics.com

How to Buy Enliven Therapeutics, Inc. (ELVN) Stock on MEXC

Eligible investors can buy real shares of Enliven Therapeutics, Inc. (ELVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ELVN and Place Your Order

Open the RealStocks trading page and search for ELVN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Enliven Therapeutics, Inc. (ELVN) stock price today?

Enliven Therapeutics, Inc. (ELVN) is currently trading at $ 59,29, down 0,61% ($0,37) from the previous close of $ 59,65. Intraday prices update in real time during regular trading hours.

2.Is ELVN stock going up or down today?

As of 2026-09-04 16:57:00, ELVN is trading at $ 59,29, down 0,61% ($0,37) from its previous close of $ 59,65. The stock has traded between $ 9,80 and $ 62,32 during today’s regular session. Past price movements do not guarantee future results.

3.What is ELVN pre-market price?

As of 2026-09-04 16:57:00, ELVN is trading at $ 59,65 in pre-market trading, unchanged from the previous close of $ 59,65. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ELVN after-hours price?

As of 2026-09-04 16:57:00, ELVN is trading at -- in after-hours trading, -- from the regular-session close of $ 59,65. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ELVN stock trading now?

ELVN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ELVN sit relative to its 52-week high and low?

Over the past 52 weeks, ELVN has traded between a low of $ 14,79 and a high of $ 62,32. At $ 59,29, the stock is positioned 93,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Enliven Therapeutics, Inc. in?

Enliven Therapeutics, Inc. (ELVN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Enliven Therapeutics, Inc.'s market capitalization and where is it listed?

Enliven Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 4,32B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ELVN valued in terms of P/E ratio and EPS?

ELVN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Enliven Therapeutics, Inc. pay a dividend?

Enliven Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.